Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19027542 | METHODS AND KITS FOR LABELING CELLULAR MOLECULES | January 2025 | June 2025 | Allow | 5 | 1 | 1 | No | No |
| 19027603 | METHODS AND KITS FOR LABELING CELLULAR MOLECULES | January 2025 | June 2025 | Allow | 5 | 1 | 1 | No | No |
| 18972564 | USE OF DNA ORIGAMI NANOSTRUCTURES FOR MOLECULAR INFORMATION BASED DATA STORAGE SYSTEMS | December 2024 | June 2025 | Allow | 6 | 1 | 1 | No | No |
| 18960791 | ASSAYS AND OTHER REACTIONS INVOLVING DROPLETS | November 2024 | March 2025 | Allow | 4 | 1 | 0 | No | No |
| 18951533 | ANALYSIS OF NUCLEIC ACID SEQUENCES | November 2024 | April 2025 | Allow | 5 | 2 | 0 | Yes | No |
| 18929514 | ANALYSIS OF NUCLEIC ACID SEQUENCES | October 2024 | February 2025 | Allow | 4 | 1 | 0 | Yes | No |
| 18918205 | METHODS AND KITS FOR LABELING CELLULAR MOLECULES | October 2024 | January 2025 | Allow | 3 | 1 | 0 | No | No |
| 18906096 | MULTIPLEX LABELING OF MOLECULES BY SEQUENTIAL HYBRIDIZATION BARCODING | October 2024 | April 2025 | Allow | 6 | 1 | 0 | No | No |
| 18893597 | METHODS FOR TREATMENT OF THYROID CANCER | September 2024 | April 2025 | Allow | 7 | 1 | 1 | No | No |
| 18887084 | METHODS AND KITS FOR LABELING CELLULAR MOLECULES | September 2024 | April 2025 | Allow | 7 | 1 | 1 | No | No |
| 18887088 | METHODS AND KITS FOR LABELING CELLULAR MOLECULES | September 2024 | April 2025 | Allow | 7 | 1 | 1 | No | No |
| 18887080 | METHODS AND KITS FOR LABELING CELLULAR MOLECULES | September 2024 | March 2025 | Allow | 6 | 1 | 1 | No | No |
| 18827961 | LINKED TARGET CAPTURE | September 2024 | May 2025 | Allow | 8 | 1 | 1 | No | No |
| 18827964 | LINKED TARGET CAPTURE | September 2024 | May 2025 | Allow | 8 | 1 | 1 | Yes | No |
| 18824319 | METHODS AND SYSTEMS FOR GENETIC ANALYSIS | September 2024 | March 2025 | Allow | 7 | 1 | 1 | No | No |
| 18823253 | METHODS FOR CLASSIFICATION OF TISSUE SAMPLES AS POSITIVE OR NEGATIVE FOR CANCER | September 2024 | February 2025 | Allow | 6 | 1 | 1 | Yes | No |
| 18810294 | PROBE-BASED ANALYSIS OF NUCLEIC ACIDS AND PROTEINS | August 2024 | June 2025 | Abandon | 10 | 1 | 0 | Yes | No |
| 18807409 | SINGLE DOMAIN ANTIBODY LIBRARIES WITH MAXIMIZED ANTIBODY DEVELOPABILITY CHARACTERISTICS | August 2024 | February 2025 | Allow | 6 | 0 | 1 | Yes | No |
| 18800910 | MACROMOLECULE ANALYSIS EMPLOYING NUCLEIC ACID ENCODING | August 2024 | December 2024 | Allow | 4 | 1 | 0 | No | No |
| 18791671 | METHODS OF SEQUENCING LINKED FRAGMENTS | August 2024 | March 2025 | Allow | 8 | 1 | 1 | No | No |
| 18791664 | METHODS OF SEQUENCING LINKED FRAGMENTS | August 2024 | January 2025 | Allow | 6 | 1 | 0 | No | No |
| 18791675 | LINKED TARGET CAPTURE | August 2024 | January 2025 | Allow | 6 | 1 | 0 | No | No |
| 18791679 | LINKED TARGET CAPTURE | August 2024 | March 2025 | Allow | 8 | 1 | 1 | Yes | No |
| 18787946 | KITS FOR ANALYSIS USING NUCLEIC ACID ENCODING AND/OR LABEL | July 2024 | March 2025 | Allow | 8 | 2 | 0 | No | No |
| 18786391 | ANALYSIS OF NUCLEIC ACID SEQUENCES | July 2024 | March 2025 | Allow | 7 | 1 | 1 | Yes | No |
| 18784019 | METHODS AND KITS FOR LABELING CELLULAR MOLECULES | July 2024 | January 2025 | Allow | 6 | 1 | 1 | No | No |
| 18770462 | SYSTEMS AND METHODS FOR BIOMOLECULE RETENTION | July 2024 | January 2025 | Allow | 7 | 1 | 1 | Yes | No |
| 18764943 | N-TERMINAL MODIFIER AGENTS AND BINDERS FOR TREATING AND ANALYZING PEPTIDES | July 2024 | July 2025 | Allow | 12 | 2 | 1 | Yes | No |
| 18764600 | EFFICIENTLY CHARACTERIZING PROTEIN-PROTEIN INTERACTIONS | July 2024 | October 2024 | Allow | 3 | 0 | 0 | Yes | No |
| 18753319 | METHODS AND KITS FOR LABELING CELLULAR MOLECULES | June 2024 | January 2025 | Allow | 7 | 1 | 1 | No | No |
| 18678577 | DETECTING MUTATIONS AND PLOIDY IN CHROMOSOMAL SEGMENTS | May 2024 | October 2024 | Allow | 5 | 1 | 0 | No | No |
| 18659334 | MACROMOLECULE ANALYSIS EMPLOYING NUCLEIC ACID ENCODING | May 2024 | March 2025 | Allow | 10 | 0 | 0 | No | No |
| 18660053 | MACROMOLECULE ANALYSIS EMPLOYING NUCLEIC ACID ENCODING | May 2024 | June 2025 | Allow | 14 | 0 | 0 | No | No |
| 18653506 | SANDWICH ASSAYS IN DROPLETS | May 2024 | November 2024 | Allow | 6 | 1 | 0 | Yes | No |
| 18650305 | METHODS AND KITS FOR LABELING CELLULAR MOLECULES | April 2024 | October 2024 | Allow | 5 | 1 | 0 | No | No |
| 18643692 | METHODS OF ENGINEERING TRANSFERRIN RECEPTOR BINDING POLYPEPTIDES | April 2024 | September 2024 | Allow | 5 | 1 | 1 | No | No |
| 18636923 | METHODS FOR DIAGNOSING AND ASSESSING DISEASE USING DRAIN FLUID | April 2024 | October 2024 | Allow | 6 | 2 | 0 | No | No |
| 18610717 | METHODS AND COMPOSITIONS USING ONE-SIDED TRANSPOSITION | March 2024 | March 2025 | Allow | 12 | 1 | 0 | No | No |
| 18592843 | DNA CONCATEMERS ON A SURFACE | March 2024 | February 2025 | Allow | 11 | 1 | 0 | Yes | No |
| 18592885 | DNA ARRAY | March 2024 | February 2025 | Allow | 11 | 1 | 0 | Yes | No |
| 18593406 | METHODS AND SYSTEMS FOR GENETIC ANALYSIS | March 2024 | November 2024 | Allow | 8 | 1 | 1 | No | No |
| 18593788 | METHODS AND SYSTEMS FOR ANALYSIS | March 2024 | December 2024 | Allow | 9 | 1 | 1 | No | No |
| 18592456 | ANTIBODY LIBRARIES WITH MAXIMIZED ANTIBODY DEVELOPABILITY CHARACTERISTICS | February 2024 | February 2025 | Allow | 12 | 1 | 1 | Yes | No |
| 18592473 | ANTIBODY LIBRARIES WITH MAXIMIZED ANTIBODY DEVELOPABILITY CHARACTERISTICS | February 2024 | February 2025 | Allow | 12 | 1 | 1 | Yes | No |
| 18592499 | ANTIBODY LIBRARIES WITH MAXIMIZED ANTIBODY DEVELOPABILITY CHARACTERISTICS | February 2024 | February 2025 | Allow | 12 | 0 | 0 | Yes | No |
| 18592484 | ANTIBODY LIBRARIES WITH MAXIMIZED ANTIBODY DEVELOPABILITY CHARACTERISTICS | February 2024 | March 2025 | Allow | 12 | 0 | 0 | Yes | No |
| 18590738 | ARRAYS INCLUDING A RESIN FILM AND A PATTERNED POLYMER LAYER | February 2024 | April 2025 | Allow | 14 | 1 | 0 | No | No |
| 18439353 | METHODS AND COMPOSITIONS FOR CELL-FREE CLONING | February 2024 | April 2025 | Allow | 14 | 2 | 0 | No | No |
| 18409174 | METHODS, COMPOSITIONS, AND SYSTEMS FOR SPATIAL ANALYSIS OF ANALYTES IN A BIOLOGICAL SAMPLE | January 2024 | May 2025 | Allow | 16 | 1 | 0 | Yes | No |
| 18536721 | METHODS AND KITS FOR LABELING CELLULAR MOLECULES | December 2023 | December 2024 | Allow | 12 | 1 | 1 | No | No |
| 18536766 | METHODS AND KITS FOR LABELING CELLULAR MOLECULES | December 2023 | November 2024 | Allow | 11 | 1 | 1 | Yes | No |
| 18534150 | DNA-BARCODED ANTIGEN MULTIMERS AND METHOD OF USE THEREOF | December 2023 | October 2024 | Abandon | 10 | 0 | 1 | No | No |
| 18520514 | METHODS AND COMPOSITIONS FOR NUCLEIC ACID ANALYSIS | November 2023 | June 2025 | Allow | 18 | 1 | 0 | No | No |
| 18510295 | ENRICHMENT OF SHORT NUCLEIC ACID FRAGMENTS IN SEQUENCING LIBRARY PREPARATION | November 2023 | April 2025 | Allow | 17 | 0 | 0 | No | No |
| 18559031 | DEUTERATED INDOLE HEPTAMETHINE CYANINE DYES | November 2023 | June 2025 | Allow | 20 | 2 | 1 | Yes | No |
| 18493211 | METHODS AND COMPOSITIONS FOR IDENTIFYING EPITOPES | October 2023 | May 2025 | Allow | 19 | 1 | 0 | No | No |
| 18492069 | MAMMALIAN CELLS AND METHODS FOR ENGINEERING THE SAME | October 2023 | November 2024 | Allow | 13 | 1 | 2 | Yes | No |
| 18465687 | DOUBLE-STRANDED SPLINT ADAPTORS WITH UNIVERSAL LONG SPLINT STRANDS AND METHODS OF USE | September 2023 | March 2025 | Allow | 18 | 2 | 1 | No | No |
| 18462747 | ENGINEERED ENVELOPED VECTORS AND METHODS OF USE THEREOF | September 2023 | March 2025 | Allow | 19 | 2 | 1 | No | No |
| 18455133 | METHODS AND KITS FOR LABELING CELLULAR MOLECULES | August 2023 | February 2025 | Allow | 17 | 1 | 1 | No | No |
| 18455113 | METHODS AND KITS FOR LABELING CELLULAR MOLECULES | August 2023 | January 2025 | Allow | 17 | 1 | 1 | Yes | No |
| 18455080 | METHODS AND KITS FOR LABELING CELLULAR MOLECULES | August 2023 | September 2024 | Allow | 13 | 2 | 1 | No | No |
| 18235616 | SYSTEMS AND METHODS FOR SAMPLE ANALYSIS | August 2023 | August 2024 | Allow | 11 | 1 | 1 | No | No |
| 18233235 | MULTIPLE BEADS PER DROPLET RESOLUTION | August 2023 | February 2025 | Allow | 18 | 1 | 0 | No | No |
| 18355946 | SINGLE CELL ANALYSIS OF TRANSPOSASE ACCESSIBLE CHROMATIN | July 2023 | April 2025 | Allow | 21 | 2 | 0 | No | No |
| 18214941 | SECOND STRAND DIRECT | June 2023 | February 2025 | Allow | 20 | 1 | 0 | No | No |
| 18340511 | INCREASING EFFICIENCY OF SPATIAL ANALYSIS IN A BIOLOGICAL SAMPLE | June 2023 | March 2025 | Allow | 21 | 1 | 0 | No | No |
| 18212868 | SEQUENCING OF NUCLEIC ACIDS VIA BARCODING IN DISCRETE ENTITIES | June 2023 | May 2025 | Allow | 23 | 1 | 0 | No | No |
| 18335851 | HIGH-THROUGHPUT MULTIPLEXED SENSITIVITY AND RESISTANCE ASSAY | June 2023 | April 2025 | Allow | 22 | 4 | 0 | Yes | No |
| 18329296 | MAMMALIAN CELL LINE FOR PROTEIN PRODUCTION AND LIBRARY GENERATION | June 2023 | November 2024 | Allow | 17 | 1 | 0 | Yes | No |
| 18326406 | CANINE ANTIBODY LIBRARIES | May 2023 | March 2025 | Allow | 22 | 1 | 0 | No | No |
| 18190288 | NANOPORE DEVICE AND METHODS OF BIOSYNTHESIS USING SAME | March 2023 | January 2024 | Allow | 10 | 0 | 0 | No | No |
| 18180622 | Spatial Indexing of Genetic Material and Library Preparation Using Hydrogel Beads and Flow Cells | March 2023 | May 2025 | Allow | 27 | 2 | 0 | Yes | No |
| 18178367 | METHODS, COMPOSITIONS, AND SYSTEMS FOR CAPTURING PROBES AND/OR BARCODES | March 2023 | December 2024 | Allow | 22 | 4 | 0 | No | No |
| 18171063 | SINGLE DOMAIN ANTIBODY LIBRARIES WITH MAXIMIZED ANTIBODY DEVELOPABILITY CHARACTERISTICS | February 2023 | March 2025 | Allow | 25 | 0 | 1 | Yes | No |
| 18099913 | PROBE SET FOR ANALYZING A DNA SAMPLE AND METHOD FOR USING THE SAME | January 2023 | June 2025 | Allow | 29 | 3 | 0 | Yes | No |
| 18153070 | DYNAMIC HUMAN HEAVY CHAIN ANTIBODY LIBRARIES | January 2023 | April 2025 | Allow | 27 | 0 | 1 | No | No |
| 18150272 | System and Method of Modular Cloning | January 2023 | April 2025 | Abandon | 28 | 0 | 1 | No | No |
| 18084955 | Methods of Preparing Dual-Indexed DNA Libraries for Bisulfite Conversion Sequencing | December 2022 | November 2024 | Allow | 23 | 1 | 0 | No | No |
| 17989296 | COMBINATORIAL SINGLE MOLECULE ANALYSIS OF CHROMATIN | November 2022 | December 2024 | Abandon | 25 | 1 | 0 | No | No |
| 18055297 | Fusion Proteins Comprising an Engineered Knottin Peptide and Uses Thereof | November 2022 | December 2024 | Allow | 26 | 2 | 0 | Yes | No |
| 18051836 | METHODS AND COMPOSITIONS FOR PREPARING NUCLEIC ACID LIBRARIES | November 2022 | October 2024 | Allow | 23 | 1 | 0 | No | No |
| 18050912 | FLEXIBLE SUBSTRATES FOR NUCLEIC ACID SYNTHESIS | October 2022 | February 2025 | Abandon | 28 | 3 | 0 | Yes | No |
| 18050715 | COMPOSITIONS AND METHODS FOR IDENTIFICATION OF ANTIGEN SPECIFIC T CELLS | October 2022 | December 2024 | Allow | 25 | 1 | 0 | Yes | No |
| 17969464 | Increasing Efficiency Of Photochemical Reactions On Substrates | October 2022 | May 2025 | Abandon | 31 | 2 | 0 | No | No |
| 18047533 | Phage-Displayed Accessible Recombinant Targeted Antibodies and Methods of Making Same | October 2022 | August 2024 | Allow | 22 | 2 | 1 | No | No |
| 17937377 | ANTIBODIES THAT BIND GLP1R | September 2022 | February 2025 | Allow | 28 | 0 | 1 | No | No |
| 17933465 | SUBSTRATES, PEPTIDE ARRAYS, AND METHODS | September 2022 | June 2025 | Allow | 33 | 0 | 1 | No | No |
| 17932117 | Fibronectin Type III Domain Based Scaffold Compositions, Methods and Uses | September 2022 | December 2024 | Allow | 28 | 0 | 0 | No | No |
| 17944306 | Barcoded Protein Array for Multiplex Single-Molecule Interaction Profiling | September 2022 | January 2025 | Allow | 28 | 1 | 1 | No | No |
| 17899860 | High-Throughput Screening Methods to Identify Small Molecule Targets | August 2022 | May 2024 | Allow | 21 | 1 | 0 | No | No |
| 17817678 | LOCUS SPECIFIC AMPLIFICATION USING ARRAY PROBES | August 2022 | May 2024 | Allow | 22 | 0 | 1 | No | No |
| 17817959 | GENERATION OF BINDING MOLECULES | August 2022 | February 2025 | Allow | 30 | 1 | 1 | No | No |
| 17881051 | ACCURATE AND MASSIVELY PARALLEL QUANTIFICATION OF NUCLEIC ACID | August 2022 | December 2024 | Abandon | 29 | 2 | 1 | No | No |
| 17879530 | ASSEMBLY OF LONG NUCLEIC ACIDS BY LIGATION USING INDEXED SPLINT OLIGOS | August 2022 | March 2025 | Allow | 31 | 1 | 2 | No | No |
| 17816691 | METHODS AND SYSTEMS FOR MASK ALIGNMENT IN MANUFACTURING PROCESS OF ARRAYS | August 2022 | June 2025 | Abandon | 35 | 0 | 1 | No | No |
| 17872042 | SYSTEMS AND METHODS FOR MASSIVELY PARALLEL COMBINATORIAL ANALYSIS OF SINGLE CELLS | July 2022 | September 2024 | Allow | 26 | 1 | 1 | Yes | No |
| 17814771 | METHODS AND KITS FOR LABELING CELLULAR MOLECULES | July 2022 | June 2024 | Allow | 22 | 3 | 0 | Yes | No |
| 17871420 | RECOMBINANT NUCLEIC ACID MOLECULE AND APPLICATION THEREOF IN PREPARATION OF CIRCULAR RNA | July 2022 | February 2025 | Allow | 31 | 5 | 0 | Yes | No |
| 17870035 | METHODS AND APPARATUSES FOR PATIENT-DERIVED MICROORGANOSPHERES | July 2022 | June 2025 | Abandon | 35 | 3 | 2 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for art-unit 1684.
With a 66.7% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 22.9% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Art Unit 1684 is part of Group 1680 in Technology Center 1600. This art unit has examined 451 patent applications in our dataset, with an overall allowance rate of 78.7%. Applications typically reach final disposition in approximately 46 months.
Art Unit 1684's allowance rate of 78.7% places it in the 53% percentile among all USPTO art units. This art unit has an above-average allowance rate compared to other art units.
Applications in Art Unit 1684 receive an average of 2.22 office actions before reaching final disposition (in the 80% percentile). The median prosecution time is 46 months (in the 1% percentile).
When prosecuting applications in this art unit, consider the following:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.